Target Name: LL22NC03-63E9.3
NCBI ID: G648691
Other Name(s): Uncharacterized LOC648691 | uncharacterized LOC648691

Understanding LL22NC03-63E9.3: A Potential Drug Target Or Biomarker

LL22NC03-63E9.3, also known as Uncharacterized LOC648691, is a protein that is expressed in various tissues and cells throughout the body. It is a member of the LOC64869 family, which is known for its role in cell signaling pathways. While more research is needed to fully understand the functions of LL22NC03-63E9.3, it is possible that the protein could be a drug target or biomarker.

The LOC64869 family is characterized by the presence of a nucleotide-binding oligomerization domain (NBD), which is a protein-coding region that is responsible for binding to specific nucleotides in the cell. This domain is found in various proteins, including LL22NC03-63E9.3. NBDs are unique in that they can form a covalent complex with small nucleotides, such as GTP and CTP, which can then influence protein activity and cell signaling pathways.

One of the key functions of LL22NC03-63E9.3 is its role in the regulation of cell signaling pathways. The protein is known to be involved in several signaling pathways, including the TGF-β pathway and the Wnt signaling pathway. TGF-β is a well-known signaling pathway that is involved in cell growth, differentiation, and repair. The TGF-β pathway is a critical pathway that regulates cell signaling, and it is thought to play a role in the development and maintenance of tissues and organs.

LL22NC03-63E9.3 is also involved in the regulation of the Wnt signaling pathway, which is a critical pathway that regulates cell growth and development. The Wnt signaling pathway is thought to play a role in the development and maintenance of tissues and organs, and it is a pathway that is closely regulated by the TGF-β pathway.

In addition to its involvement in cell signaling pathways, LL22NC03-63E9.3 is also known to be involved in the regulation of cellular processes such as cell adhesion, migration, and invasion. The protein is thought to play a role in the regulation of these processes, and it is possible that it may be a drug target or biomarker that can be targeted by small molecules or other therapeutic agents.

While more research is needed to fully understand the functions of LL22NC03-63E9.3, it is clear that the protein is involved in several important cellular processes. As such, it is possible that the protein could be a drug target or biomarker that can be targeted by small molecules or other therapeutic agents. Further research is needed to determine the full potential of LL22NC03-63E9.3 as a drug target or biomarker.

Protein Name: Uncharacterized LOC648691

More Common Targets

LLCFC1 | LLGL1 | LLGL2 | LLPH | LMAN1 | LMAN1L | LMAN2 | LMAN2L | LMBR1 | LMBR1L | LMBRD1 | LMBRD2 | LMCD1 | LMCD1-AS1 | LMF1 | LMF2 | LMLN | LMNA | LMNB1 | LMNB2 | LMNTD1 | LMNTD2 | LMNTD2-AS1 | LMO1 | LMO2 | LMO3 | LMO4 | LMO7 | LMO7-AS1 | LMO7DN | LMOD1 | LMOD2 | LMOD3 | LMTK2 | LMTK3 | LMX1A | LMX1B | LMX1B-DT | LNC-LBCS | LNCAROD | LNCARSR | LNCATV | LNCNEF | LNCOC1 | LNCOG | LNCPRESS1 | LNCRI | LNCRNA-ATB | LNCRNA-IUR | LNCTAM34A | LNP1 | LNPEP | LNPK | LNX1 | LNX1-AS1 | LNX2 | LOC100127946 | LOC100127955 | LOC100128002 | LOC100128028 | LOC100128050 | LOC100128059 | LOC100128079 | LOC100128093 | LOC100128164 | LOC100128242 | LOC100128288 | LOC100128317 | LOC100128361 | LOC100128398 | LOC100128494 | LOC100128593 | LOC100128770 | LOC100128966 | LOC100128988 | LOC100129034 | LOC100129098 | LOC100129148 | LOC100129175 | LOC100129203 | LOC100129215 | LOC100129316 | LOC100129381 | LOC100129434 | LOC100129455 | LOC100129534 | LOC100129603 | LOC100129697 | LOC100130000 | LOC100130207 | LOC100130285 | LOC100130298 | LOC100130331 | LOC100130452 | LOC100130463 | LOC100130548 | LOC100130587 | LOC100130691 | LOC100130698 | LOC100130744